Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 31545 | 121 | 32.5 | 63% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 232 | 19686 | TAMOXIFEN//AROMATASE INHIBITORS//ANASTROZOLE |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CRLC OSCAR LAMBRET | Address | 3 | 60% | 2% | 3 |
| 2 | UKRAINIAN ONCOL RADIOL | Address | 2 | 67% | 2% | 2 |
| 3 | 6 METHYL 1 3 8 TRICHLORODIBENZOFURAN | Author keyword | 1 | 50% | 1% | 1 |
| 4 | CHINA TIANJIN BREAST CANC PREVENT | Address | 1 | 50% | 1% | 1 |
| 5 | COBALT 60 RADIOTHERAPY | Author keyword | 1 | 50% | 1% | 1 |
| 6 | ESTROGEN HYPERSENSITIVITY | Author keyword | 1 | 50% | 1% | 1 |
| 7 | HYPERSENSITIVE PATIENTS | Author keyword | 1 | 50% | 1% | 1 |
| 8 | PULSE SELECTION | Author keyword | 1 | 50% | 1% | 1 |
| 9 | S STOCKHOLM HOSP | Address | 1 | 50% | 1% | 1 |
| 10 | BREAST FIBROSIS | Author keyword | 0 | 33% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | 6 METHYL 1 3 8 TRICHLORODIBENZOFURAN | 1 | 50% | 1% | 1 | Search 6+METHYL+1+3+8+TRICHLORODIBENZOFURAN | Search 6+METHYL+1+3+8+TRICHLORODIBENZOFURAN |
| 2 | COBALT 60 RADIOTHERAPY | 1 | 50% | 1% | 1 | Search COBALT+60+RADIOTHERAPY | Search COBALT+60+RADIOTHERAPY |
| 3 | ESTROGEN HYPERSENSITIVITY | 1 | 50% | 1% | 1 | Search ESTROGEN+HYPERSENSITIVITY | Search ESTROGEN+HYPERSENSITIVITY |
| 4 | HYPERSENSITIVE PATIENTS | 1 | 50% | 1% | 1 | Search HYPERSENSITIVE+PATIENTS | Search HYPERSENSITIVE+PATIENTS |
| 5 | PULSE SELECTION | 1 | 50% | 1% | 1 | Search PULSE+SELECTION | Search PULSE+SELECTION |
| 6 | BREAST FIBROSIS | 0 | 33% | 1% | 1 | Search BREAST+FIBROSIS | Search BREAST+FIBROSIS |
| 7 | GUERIN CARCINOMA | 0 | 20% | 1% | 1 | Search GUERIN+CARCINOMA | Search GUERIN+CARCINOMA |
| 8 | RBL2 | 0 | 13% | 1% | 1 | Search RBL2 | Search RBL2 |
| 9 | NUCLEAR RECEPTOR COREPRESSOR | 0 | 11% | 1% | 1 | Search NUCLEAR+RECEPTOR+COREPRESSOR | Search NUCLEAR+RECEPTOR+COREPRESSOR |
| 10 | SUBCUTANEOUS FIBROSIS | 0 | 11% | 1% | 1 | Search SUBCUTANEOUS+FIBROSIS | Search SUBCUTANEOUS+FIBROSIS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | NODE NEGATIVE BREAST | 1 | 50% | 1% | 1 |
| 2 | OSTEOSARCOMA CELL LINE | 0 | 10% | 2% | 3 |
| 3 | PREDICTS POOR RESPONSE | 0 | 20% | 1% | 1 |
| 4 | P53 GENE EXPRESSION | 0 | 17% | 1% | 1 |
| 5 | WNT 1 TRANSGENIC MICE | 0 | 11% | 1% | 1 |
| 6 | B ALPHA DEGRADATION | 0 | 10% | 1% | 1 |
| 7 | EXCESS THYMIDINE | 0 | 100% | 1% | 1 |
| 8 | ZK98299 | 0 | 100% | 1% | 1 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| How to combine hormonotherapy and radiation treatment in adjuvant breast cancer? | 2008 | 4 | 27 | 30% |
| Concurrent hormone and radiation therapy in patients with breast cancer: what is the rationale? | 2009 | 17 | 61 | 28% |
| Neoadjuvant Radiotherapy and Hormonotherapy in Locally Advanced Breast Cancer: State of the Art | 2012 | 2 | 23 | 39% |
| Breast cancer: radiotherapy and estrogen signaling | 2014 | 0 | 28 | 39% |
| Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy | 2007 | 33 | 70 | 9% |
| Adjuvant breast cancer treatment with hormono-radiotherapy | 2009 | 1 | 24 | 29% |
| Combination of anti-estrogenic therapy with radiation in breast cancer: Simultaneous or sequential treatment? | 2005 | 3 | 14 | 29% |
| Letrozole sensitizes breast cancer cells to ionizing radiation | 2005 | 24 | 25 | 12% |
| Interactions between radiation and endocrine therapy in breast cancer | 2003 | 25 | 63 | 11% |
| Combining systemic therapies with radiation in breast cancer | 2009 | 6 | 72 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CRLC OSCAR LAMBRET | 3 | 60% | 2.5% | 3 |
| 2 | UKRAINIAN ONCOL RADIOL | 2 | 67% | 1.7% | 2 |
| 3 | CHINA TIANJIN BREAST CANC PREVENT | 1 | 50% | 0.8% | 1 |
| 4 | S STOCKHOLM HOSP | 1 | 50% | 0.8% | 1 |
| 5 | SEKT STRAHLENBIOL | 0 | 33% | 0.8% | 1 |
| 6 | U860 | 0 | 17% | 1.7% | 2 |
| 7 | SERV RADIO ONCOL | 0 | 15% | 1.7% | 2 |
| 8 | THER EUT RADIAT | 0 | 25% | 0.8% | 1 |
| 9 | UNIV NSW | 0 | 25% | 0.8% | 1 |
| 10 | JEAN CLAUDE HEUSON CANCEROL MAMMAIRE | 0 | 13% | 1.7% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000128641 | BUCCAL DRUG ABSORPTION//HUMAN ENDOMETRIAL ADENOCARCINOMA//BIOL CHEM ERNAHRUNGSWISSEN AFT |
| 2 | 0.0000108250 | PREDICTIVE ASSAYS//INDIVIDUAL RADIOSENSITIVITY//NORMAL TISSUE RESPONSE |
| 3 | 0.0000103763 | AEBS//ANTIESTROGEN BINDING SITES//ANALOG II |
| 4 | 0.0000101567 | RADIATION PNEUMONITIS//RADIATION INDUCED LUNG INJURY//RADIATION INDUCED LUNG TOXICITY |
| 5 | 0.0000083151 | ACCELERATED PARTIAL BREAST IRRADIATION//PARTIAL BREAST IRRADIATION//BREAST CONSERVING THERAPY |
| 6 | 0.0000077889 | NBD GLUCOSAMINE//// |
| 7 | 0.0000066966 | AROMATASE INHIBITORS//EXEMESTANE//ANASTROZOLE |
| 8 | 0.0000065854 | P53 GENE//P53 MUTANTS//MUTANT P53 |
| 9 | 0.0000065436 | ESTROGEN RECEPTOR BETA//ER BETA//RECEPTOR BIOL SECT |
| 10 | 0.0000064513 | ESTROGEN RECEPTOR VARIANTS//JC HEUSON CANCEROL MAMMAIRE//SERV HISTOL CYTOL EXPT |